- SRPT has an average dollar-volume (as measured by average daily share volume multiplied by share price) of $21.7 million.
- SRPT has traded 416,857 shares today.
- SRPT is down 3% today.
- SRPT was up 5.6% yesterday.
EXCLUSIVE OFFER: Get the inside scoop on opportunities in SRPT with the Ticky from Trade-Ideas. See the FREE profile for SRPT NOW at Trade-Ideas More details on SRPT: Sarepta Therapeutics, Inc., a biopharmaceutical company, focuses on the discovery and development of RNA-based therapeutics for the treatment of rare and infectious diseases. Currently there are 5 analysts that rate Sarepta Therapeutics a buy, no analysts rate it a sell, and 8 rate it a hold. The average volume for Sarepta Therapeutics has been 1.6 million shares per day over the past 30 days. Sarepta has a market cap of $649.8 million and is part of the health care sector and drugs industry. The stock has a beta of 1.68 and a short float of 35.9% with 10.11 days to cover. Shares are down 18.5% year-to-date as of the close of trading on Monday. STOCKS TO BUY: TheStreet Quant Ratings has identified a handful of stocks that can potentially TRIPLE in the next 12 months. Learn more.